Clinical Trials
15 trialsNCT05803096 2024-01-30
Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain
Beth Israel Deaconess Medical Center
Phase 4 Completed
NCT02351700 2021-10-21
Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors
St. Joseph's Hospital and Medical Center, Phoenix
Phase 4 Completed
NCT01812759 2021-06-29
Fentanyl for Breakthrough Pain in the Emergency Department
M.D. Anderson Cancer Center
Phase 4 Terminated
NCT02459964 2021-06-16
Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain
M.D. Anderson Cancer Center
Phase 4 Completed
NCT03723447 2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4 Completed
NCT00380874 2021-02-11
Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer
Pfizer
Phase 4 Terminated
NCT01264965 2020-12-11
Non-cancer Pain and Cognitive Impairment: A Disabling Relationship
University of Chicago
Phase 4 Terminated
NCT01982539 2020-05-07
Safety and Tolerability of Zipsor® in Pediatric Subjects (Ages 12-17 Years) With Mild to Moderate Acute
Depomed
Phase 4 Completed
NCT02839889 2019-03-05
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
Hospice of Henderson County, Inc.
Phase 4 Terminated
NCT02227316 2018-06-08
Effectiveness of IV Acetaminophen and IV Ibuprofen in Reducing Post Procedural Pain in the UFE Procedure
University of California, Los Angeles
Phase 4 Completed
NCT02287350 2017-07-11
Pharmacokinetics & Safety of Diclofenac Potassium Oral Solution in Ped. Subjects (2-12 Yrs) With Mild-Mod. Acute Pain
Depomed
Phase 4 Completed
NCT02684942 2017-06-01
Comparison of Meperidine and Fentanyl on Pain Scale and QOL in Brachytherapy
Chulabhorn Cancer Center
Phase 4 Completed
NCT00365261 2016-07-11
Effect of Eszopiclone on Sleep Disturbance and Pain in Cancer
University of California, San Diego
Phase 4 Completed
NCT01648699 2013-10-11
Safety and Efficacy Study of Osmotic Release Oral System (OROS) Hydromorphone in Participants With Cancer Pain
Janssen Pharmaceutica
Phase 4 Terminated
NCT01006356 2013-08-08
An Efficacy and Safety Study of Hydromorphone Hydrochloride (HCl) Oral Osmotic System (OROS) in the Reduction of Breakthrough Pain Medication Frequency in Participants With Cancer
Janssen Korea, Ltd., Korea
Phase 4 Completed